
Radiation therapy
for pituitary tumors
in pets — Florida.
Pituitary macroadenomas cause both neurological compression and hormonal overproduction. Radiation therapy targets the tumor directly — controlling growth, reversing neurological deficits, and improving hormonal regulation simultaneously.
“The only center 100% dedicated to Radiation Oncology in Florida”
One tumor, two problems —
radiation addresses both.
The pituitary gland sits at the base of the brain. Tumors here — whether microadenomas or macroadenomas — affect two systems simultaneously: they compress brain structures as they grow, and they produce excess hormones that disrupt the body's regulation. Radiation therapy is uniquely positioned to address both problems with a single, well-targeted treatment course.
In dogs, pituitary tumors are the most common cause of Cushing's disease (hyperadrenocorticism) — a hormonal disorder characterized by increased thirst, urination, pot-belly appearance, hair loss, and skin changes. When the tumor grows large enough to become a macroadenoma, neurological signs emerge: seizures, behavioral changes, circling, visual deficits, and incoordination.
When to consider radiation
Dogs with pituitary-dependent Cushing's disease managed medically but showing neurological signs — or dogs with a confirmed pituitary macroadenoma on MRI — are candidates for radiation therapy. RT is also considered when medical management of Cushing's becomes difficult due to escalating tumor size. Early intervention — before significant neurological damage has occurred — consistently produces better outcomes.
What radiation achieves for pituitary tumors
Radiation controls local tumor growth, relieves intracranial compression, and reduces ACTH secretion — leading to improved hormonal control and neurological stabilization. Most dogs treated with definitive radiation for pituitary macroadenoma achieve median survivals of 12–20 months. Neurological improvement is typically seen within weeks of completing treatment, and hormonal improvement often allows reduction in medical management.
Precision targeting
at the base of the brain.
Pituitary tumor treatment at AARADONC begins with a complete case review — MRI, hormonal workup, neurological status, and current medical management. Dr. DiBernardi designs every plan personally and coordinates with your primary team throughout.
Varian TrueBeam® + IGRT. Cone Beam CT before every session confirms exact positioning for the pituitary target — a structure adjacent to the optic chiasm, hypothalamus, and brainstem, where precision is non-negotiable.
SRS/SRT for well-defined tumors. 1–5 ablative sessions with VMAT/RapidArc deliver high-precision doses to the pituitary tumor while protecting adjacent critical structures. Outpatient — same-day home.
CFRT for large macroadenomas. 15–20 fractionated sessions allow dose escalation for larger tumors while protecting surrounding brain tissue through dose fractionation.
SRS/SRT or CFRT — chosen by tumor size and imaging.
What pet owners
ask us most.
Same-day response.
Dr. DiBernardi personally reviews every case. Tell us about your pet and we'll respond the same day with a clear, honest recommendation.
Request a Consultationa pituitary tumor.
Submit a referral and receive same-day acknowledgment. We coordinate radiation with your internal medicine team throughout treatment.
Referral Information →